Multinational Pharmaceutical Companies: the case for investing in Norway
Arrangør
American Chamber of Commerce in Norway
Dag
Torsdag 18/8 2016 13:15 - 14:30
Arrangementstype
Samtale
Tema
Næringsliv
, Helse
Språk
English
Sted
Clarion Hotel Tyholmen
Stedsbeskrivelse:
meeting room B, ground floor
Om arrangementet
Multinational pharmaceutical companies have developed the majority of medicines used in Norway today, yet the size of the local sector is below average and the smallest of all Nordic countries.
How can the pharmaceutical industry best flourish in Norway?
Join health committee parliamentarians, directors of Roche and GE Healthcare and BI's Dag Morten Dalen as we examine the best path forward.
Medvirkende
Dag Morten Dalen, Professor, BI Norwegian Business School
Bjørn Fuglaas, General Manager, GE Healthcare
Bård Hoksrud (FrP), Health Committee member, Norwegian Parliament
Elizabeth Jeffords, General Manager, Roche Norge
Sveinung Stensland (H), Health Committee member, Norwegian Parliament
Jason Turflinger, Managing Director, American Chamber of Commerce in Norway
Rullestoltilpasset lokale
Rullestoltilpasset WC
